Figure 4

Results of the network meta-analysis for antidiabetic agents in terms of (A) MI, (B) angina (upper right triangle) and CAD (lower left triangle). Results were presented as OR with 95% CrI, the estimations should read as column-defining treatment compared with the row-defining treatment. The OR below 1 was identified that the column-defining treatment had better effect on the cardiovascular risk. Use of DPP-4 inhibitors and GLP-1 agonists shown high probability with lower risk of myocardial infarction events as compared to use of sulfonylureas. OR = odds ratios. CrI = credible interval. * = 95% CrI did not include 1.